214 related articles for article (PubMed ID: 28872473)
1. Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study.
Gálvez R; Navez ML; Moyle G; Maihöfner C; Stoker M; Ernault E; Nurmikko TJ; Attal N
Clin J Pain; 2017 Oct; 33(10):921-931. PubMed ID: 28872473
[TBL] [Abstract][Full Text] [Related]
2. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.
Vinik AI; Perrot S; Vinik EJ; Pazdera L; Jacobs H; Stoker M; Long SK; Snijder RJ; van der Stoep M; Ortega E; Katz N
BMC Neurol; 2016 Dec; 16(1):251. PubMed ID: 27919222
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
[TBL] [Abstract][Full Text] [Related]
4. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
Maihofner C; Heskamp ML
Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
[TBL] [Abstract][Full Text] [Related]
5. NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
Simpson DM; Brown S; Tobias JK; Vanhove GF;
Clin J Pain; 2014 Feb; 30(2):134-42. PubMed ID: 23446088
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
Simpson DM; Gazda S; Brown S; Webster LR; Lu SP; Tobias JK; Vanhove GF;
J Pain Symptom Manage; 2010 Jun; 39(6):1053-64. PubMed ID: 20538187
[TBL] [Abstract][Full Text] [Related]
7. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
Goncalves D; Rebelo V; Barbosa P; Gomes A
Pain Physician; 2020 Sep; 23(5):E541-E548. PubMed ID: 32967405
[TBL] [Abstract][Full Text] [Related]
8. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
[TBL] [Abstract][Full Text] [Related]
9. Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
Burness CB; McCormack PL
Drugs; 2016 Jan; 76(1):123-34. PubMed ID: 26666418
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.
Webster LR; Peppin JF; Murphy FT; Lu B; Tobias JK; Vanhove GF
Diabetes Res Clin Pract; 2011 Aug; 93(2):187-197. PubMed ID: 21612836
[TBL] [Abstract][Full Text] [Related]
11. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
Hansson P; Jensen TS; Kvarstein G; Strömberg M
Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin 8% Patch for Central and Peripheral Neuropathic Pain of Persons with Incomplete Spinal Cord Injury: Two Case Reports.
Trbovich M; Yang H
Am J Phys Med Rehabil; 2015 Aug; 94(8):e66-72. PubMed ID: 26035723
[TBL] [Abstract][Full Text] [Related]
13. Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?
Kern KU; Nowack W; Poole C
Pain Pract; 2014 Feb; 14(2):E42-50. PubMed ID: 24289500
[TBL] [Abstract][Full Text] [Related]
14. High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience.
Filipczak-Bryniarska I; Krzyzewski RM; Kucharz J; Michalowska-Kaczmarczyk A; Kleja J; Woron J; Strzepek K; Kazior L; Wordliczek J; Grodzicki T; Krzemieniecki K
Med Oncol; 2017 Aug; 34(9):162. PubMed ID: 28819738
[TBL] [Abstract][Full Text] [Related]
15. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
Wagner T; Poole C; Roth-Daniek A
Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
[TBL] [Abstract][Full Text] [Related]
16. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
Katz NP; Mou J; Paillard FC; Turnbull B; Trudeau J; Stoker M
Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany.
Kern KU; Quandel T; Theis S; Schubert T
Pain Pract; 2024 Jun; 24(5):700-708. PubMed ID: 38321913
[TBL] [Abstract][Full Text] [Related]
19. Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.
Mainka T; Malewicz NM; Baron R; Enax-Krumova EK; Treede RD; Maier C
Eur J Pain; 2016 Jan; 20(1):116-29. PubMed ID: 25854794
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Impact of Capsaicin 8% Patch on Quality of Life in Patients with Lumbosacral Pain: An Open-label Study.
Zis P; Bernali N; Argira E; Siafaka I; Vadalouka A
Pain Physician; 2016; 19(7):E1049-53. PubMed ID: 27676676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
